The Latest Breaking News from Neogen Corporation

Profit Potential or Red Flags? Evaluating Neogen (NEOG) for Investors

Neogen Corporation's (NEOG) latest quarter’s earnings release revealed weak financials and strategic challenges in its Genomics division, prompting a reassessment of fiscal 2024 projections. Given this, should investors now decide to load up on its shares or heed potential red flags? Read more to find out.

StockNews.com · Jan 19, 2024

Here's Why Niogen Shares Are Falling

Neogen Corporation (NASDAQ: NEOG) shares are trading lower by 9.6% at $30.51 after the company reported worse-than-expected third-quarter EPS and sales results.

Benzinga · Mar 24, 2022